Skip to main content

3 Result(s)

within Nava Siegelmann-Danieli Remove this filter

and
Your search also matched 5 preview-only Content is preview-only when you or your institution have not yet subscribed to it.

By making our abstracts and previews universally accessible we help you purchase only the content that is relevant to you. results, e.g.

Breast cancer survivors: physical and mental quality of life 10 years following diagnosis, a case-control study

Include preview-only content

  1. Article

    Open Access

    The reimbursement process in three national healthcare systems: variation in time to reimbursement of pembrolizumab for metastatic non-small cell lung cancer

    In this article, we focus on the reimbursement process, and as an example, characterize the time to reimbursement of pembrolizumab, a PD-1 immune checkpoint inhibitor for treatment of metastatic NSCLC from public...

    Sarah Sharman Moser, Frank Tanser… in Journal of Pharmaceutical Policy and Pract… (2023)

    Download PDF (910 KB) View Article

  2. Article

    Open Access

    Does levonorgestrel-releasing intrauterine system increase breast cancer risk in peri-menopausal women? An HMO perspective

    To evaluate the association between levonorgestrel-releasing intrauterine system (LNG-IUS) use and breast cancer (BC) risk.

    Nava Siegelmann-Danieli, Itzhak Katzir… in Breast Cancer Research and Treatment (2018)

    Download PDF (549 KB) View Article

  3. Article

    Open Access

    Trends in annual drug expenditure – a 16 year perspective of a public healthcare maintenance organization

    Modern drug therapy accounts for a major share of health expenditure and challenges public provider resources. The objective of our study was to compare drug expenditure trends for ten major drug classes over ...

    Yossef Lomnicky, Daniel Kurnik, Ronen Loebstein… in Israel Journal of Health Policy Research (2016)

    Download PDF (946 KB) View Article